A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Conditions
Triple Negative Breast Cancer · HER2-negative Breast Cancer · Non Small Cell Lung Cancer · Cervical Cancer · Castrate Resistant Prostate Cancer · Pancreatic Ductal Adenocarcinoma · Head-and-neck Squamous Cell Carcinoma · Endometrial Cancer · Ovarian Cancer · Gastric Cancer · Gastroesophageal-junction Cancer · Urothelial Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Dren Investigational Site, Denver, Colorado, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Orlando, Florida, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Sarasota, Florida, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Huntersville, North Carolina, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Greenville, South Carolina, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Austin, Texas, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Dallas, Texas, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, San Antonio, Texas, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Fairfax, Virginia, United States
Contact: Study coordinator (Dren Bio Central Contact) · DR-0202-ONC-001_inquiries@drenbio.com · 415-737-5277
Study leads
Wan Jen Hong, MD
Study Director
Dren Bio